POSTER: ALL-351 Inotuzumab Ozogamicin in the Treatment of Relapsed/Refractory (R/R) Ph-Positive Acute Lymphoid Leukemia (ALL) With Extramedullary Disease: Our Experience
{"title":"POSTER: ALL-351 Inotuzumab Ozogamicin in the Treatment of Relapsed/Refractory (R/R) Ph-Positive Acute Lymphoid Leukemia (ALL) With Extramedullary Disease: Our Experience","authors":"M. Dragoescu, A. Ghiaur, D. Coriu","doi":"10.1016/s2152-2650(23)00399-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00399-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
